A possible explanation for the poorer response rates seen in tumors overexpressing B7H3 could be that B7H3 activates the ERK 1/2 signaling pathway, known to cause radio resistance in colorectal cancer [17,31]. The gene discussed is CD276; the disease is colorectal cancer.